Swiss drugmakers Novartis and Roche ditch some diversity programs on U.S. concerns
Swiss drugmaker Roche has abandoned global diverse workforce targets, and compatriot Novartis is ending its use of diverse panels for U.S. hiring.
You are not logged in so some information on this page has been withheld. To see more, please log in.